SLAMF7 and neoplasm: Flow cytometry results indicated that the mixed injection of MSCs expressing both IL‐12 and nCD47‐SLAMF7 led to a notable increase in DC cell maturation and activation within the TIME (Figure 6B), induced a greater release of pro‐inflammatory cytokines such as IFN‐γ from effector CD8+ T cells (Figure 6D), and enhanced the infiltration of TCF‐1+ T cells (Figure 6E), contributing to a more sustained anti‐tumor immune response.